title: HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.
abstract: We investigated the HE4 variant-specific expression patterns in various normal tissues as well as in normal and malignant endometrial tissues. The relationships between mRNA variants and age, body weight, or survival are analyzed. ICAT-labeled normal and endometrial cancer (EC) tissues were analyzed with multidimensional liquid chromatography followed by tandem mass spectrometry. Levels of HE4 mRNA variants were measured by real-time PCR. Mean mRNA levels were compared among 16 normal endometrial samples, 14 grade 1 and 14 grade 3 endometrioid EC, 15 papillary serous EC, and 14 normal human tissue samples. The relationship between levels of HE4 variants and EC patient characteristics was analyzed with the use of Pearson correlation test. We found that, although all five HE4 mRNA variants are detectable in normal tissue samples, their expression is highly tissue-specific, with epididymis, trachea, breast and endometrium containing the highest levels. HE4-V0, -V1, and -V3 are the most abundant variants in both normal and malignant tissues. All variants are significantly increased in both endometrioid and papillary serous EC, with higher levels observed in grade 3 endometrioid EC. In the EC group, HE4-V1, -V3, and -V4 levels inversely correlate with EC patient survival, whereas HE4-V0 levels positively correlate with age. HE4 variants exhibit tissue-specific expression, suggesting that each variant may exert distinct functions in normal and malignant cells. HE4 levels appear to correlate with EC patient survival in a variant-specific manner. When using HE4 as a biomarker for EC management, the effects of age should be considered.
authors.affiliation: Department of Biomedical Science, School of Medicine, Mercer University, Savannah, GA 31404, USA. li_j@mercer.edu.
authors.forename: Shi-Wen
authors.initials: SW
authors.lastname: Jiang
authors.forename: Haibin
authors.initials: H
authors.lastname: Chen
authors.forename: Sean
authors.initials: S
authors.lastname: Dowdy
authors.forename: Alex
authors.initials: A
authors.lastname: Fu
authors.forename: John
authors.initials: J
authors.lastname: Attewell
authors.forename: Eleftheria
authors.initials: E
authors.lastname: Kalogera
authors.forename: Ronny
authors.initials: R
authors.lastname: Drapkin
authors.forename: Karl
authors.initials: K
authors.lastname: Podratz
authors.forename: Russell
authors.initials: R
authors.lastname: Broaddus
authors.forename: Jinping
authors.initials: J
authors.lastname: Li
mesh_terms: D016889:Endometrial Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009367:Neoplasm Staging; D020033:Protein Isoforms / Q000096:biosynthesis*; D011506:Proteins / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D016019:Survival Analysis; D014158:Transcription, Genetic; D000081102:WAP Four-Disulfide Core Domain Protein 2
chemical_list: D020033:Protein Isoforms; D011506:Proteins; D012333:RNA, Messenger; D000081102:WAP Four-Disulfide Core Domain Protein 2; C569698:WFDC2 protein, human